Abstract:Background The purpose of this study was to retrospectively assess the potential correlation between clinical outcomes and homocysteine (Hcy) levels in acute ischemic stroke (AIS) patients after recombinant tissue plasminogen activator (rtPA) treatment. Methods AIS patients treated by rtPA were enrolled between September 2018 and March 2019 in the Stroke Center (Department of Neurology and Neurosurgery), Shanghai Tenth People’s Hospital, Tongji University School of Medicine. Demographics, baseline and clinical characteristics, and modified Rankin Scale (mRS) score after three months from the onset were retrospectively analyzed. Then we compared data about demographics, baseline and clinical characteristics between patients with favorable (mRS score 0–2) and unfavorable (mRS score 3–6) outcomes. Results Among 141 patients, 36 patients had poor outcome, for an incidence of 25.53%. Univariate analysis showed that higher Hcy levels (OR = 1.07, 95% CI [1.02–1.12]), older age (OR = 1.06, 95% CI [1.02–1.10]), longer door to needle time (DNT) (OR = 1.03, 95% CI [1.01–1.05]), higher D-Dimer levels (OR = 1.33, 95% CI [1.03–1.71]), and higher National Institutes of Health Stroke Scale (NIHSS) score before treatment (OR = 1.21, 95% CI [1.08–1.35]) were each associated with poor outcome. Also, without internal carotid artery plaque (OR = 0.30, 95% CI [0.10–0.92]) showed a protective effect on patients’ clinical outcome. Patients with higher levels of Hcy decline also showed an increased risk of poor outcome for AIS patients obtaining rtPA treatment (Non-adjusted: OR = 1.07, 95% CI [1.02–1.12]; Adjust model I adjusts for demographics (age, male): OR = 1.06, 95% CI [1.02–1.11]; Adjust model II adjusts for hospital care factors (onset to treatment, DNT): OR = 1.08, 95% CI [1.03–1.13]; Adjust model III adjusts for health and stroke factors (INR, D-Dimer, HGB, NIHSS score before treatment, smoking, drinking, hypertension, diabetes, coronary disease, hyperlipidemia, previous stroke, atrial fibrillation, hemorrhagic transformation, internal carotid artery plaque): OR = 1.06, 95% CI [1.02–1.11]). The results are very stable in all three models constructed. Conclusion The results of this study indicate that increased Hcy level independently predicts unfavorable outcome in AIS patients accepting thrombolytic therapy. However, the contribution of Hcy to the outcome, although significant, is relatively small and perhaps not clinically significant when all the other confounders are considered.

The Association Between Plasma Neurotransmitters Levels and Depression in Acute Hemorrhagic Stroke

Low Hemoglobin Levels at Admission Are Independently Associated with Cognitive Impairment after Ischemic Stroke: a Multicenter, Population-Based Study

Association between baseline hemoglobin level and early neurological deterioration after intravenous thrombolysis in patients with acute ischemic stroke.

Plasma levels of glutamate during stroke is associated with development of post-stroke depression

Analysis of ~1H-MRS in patients with depression after basal ganglia infarction

Plasma Amino Acid Neurotransmitters and Ischemic Stroke Prognosis: A Multicenter Prospective Study

Correlations Of Encephalic Neurotransmitters With Contingent Negative Variation (Cnv) In Post-Stroke Depression Patients

A study of the alteration of plasma monoamine neurotransmitters in comorbid anxiety and depression after acute stroke

Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression

The Combination of Plasma Glutamate and Physical Impairment after Acute Stroke As a Potential Indicator for the Early-Onset Post-Stroke Depression

The protein and mRNA expression levels of glial cell line-derived neurotrophic factor in post stroke depression and major depressive disorder

Serum levels of homocysteine at admission are associated with post-stroke depression in acute ischemic stroke

A reduced concentration of brain interstitial amino acids is associated with depression in subarachnoid hemorrhage patients

Relation between serum excitatory amino acids and recovery of neurological function in patients with cerebral hemorrhage

Plasma and Cerebrospinal Fluid Substance P in Post‐stroke Patients with Depression

Impact of Homocysteine Levels on Clinical Outcome in Patients with Acute Ischemic Stroke Receiving Intravenous Thrombolysis Therapy

Study of 5-HT Concentration in Blood of Post-stroke Depression Patients

Serum Brain-derived Neurotrophic Factor Levels in Post-Stroke Depression.

The Changes of Monamine Transmitter Content in Plasm of Post-Stroke Depression Patients and the Effect of Fluoxetine Hydrochloride to Post-Stroke Depression Treatment

Relationship Between Uric Acid Levels in Patients with Acute Ischemic Stroke and Discharged Outcome

[Association study of serum uric acid levels with clinical outcome and hemorrhagic transformation in stroke patients with rt-PA intravenous thrombolysis].